Literature DB >> 16601073

Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers.

Hong Jiang1, Lorena Betancourt, Roy G Smith.   

Abstract

Our objective is to determine the neuromodulatory role of ghrelin in the brain. To identify neurons that express the ghrelin receptor [GH secretagogue receptor (GHS-R)], we generated GHS-R-IRES-tauGFP mice by gene targeting. Neurons expressing the GHS-R exhibit green fluorescence and are clearly evident in the hypothalamus, hippocampus, cortex, and midbrain. Using immunohistochemistry in combination with green fluorescent protein fluorescence, we identified neurons that coexpress the dopamine receptor subtype 1 (D1R) and GHS-R. The potential physiological relevance of coexpression of these two receptors and the direct effect of ghrelin on dopamine signaling was investigated in vitro. Activation of GHS-R by ghrelin amplifies dopamine/D1R-induced cAMP accumulation. Intriguingly, amplification involves a switch in G protein coupling of the GHS-R from Galpha(11/q) to Galpha(i/o) by a mechanism consistent with agonist-dependent formation of GHS-R/D1R heterodimers. Most importantly, these results indicate that ghrelin has the potential to amplify dopamine signaling selectively in neurons that coexpress D1R and GHS-R.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601073     DOI: 10.1210/me.2005-0084

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  94 in total

1.  Growth hormone secretagogue receptor (GHS-R1a) knockout mice exhibit improved spatial memory and deficits in contextual memory.

Authors:  Rosie G Albarran-Zeckler; Alicia Faruzzi Brantley; Roy G Smith
Journal:  Behav Brain Res       Date:  2012-03-31       Impact factor: 3.332

2.  Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism.

Authors:  Andras Kern; Rosie Albarran-Zeckler; Heidi E Walsh; Roy G Smith
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

Review 3.  Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine.

Authors:  Paul E M Phillips; Mark E Walton; Thomas C Jhou
Journal:  Psychopharmacology (Berl)       Date:  2006-11-22       Impact factor: 4.530

Review 4.  Gut feelings: the emerging biology of gut-brain communication.

Authors:  Emeran A Mayer
Journal:  Nat Rev Neurosci       Date:  2011-07-13       Impact factor: 34.870

Review 5.  The hormonal signature of energy deficit: Increasing the value of food reward.

Authors:  Sarah H Lockie; Zane B Andrews
Journal:  Mol Metab       Date:  2013-08-19       Impact factor: 7.422

6.  Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.

Authors:  Lorenzo Leggio; William H Zywiak; Samuel R Fricchione; Steven M Edwards; Suzanne M de la Monte; Robert M Swift; George A Kenna
Journal:  Biol Psychiatry       Date:  2014-03-25       Impact factor: 13.382

7.  Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice.

Authors:  A Akubuiro; M Bridget Zimmerman; L L Boles Ponto; S A Walsh; J Sunderland; L McCormick; M Singh
Journal:  Genes Brain Behav       Date:  2013-02-18       Impact factor: 3.449

8.  Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention.

Authors:  Jeffrey S Davies; Pia Kotokorpi; Sinan R Eccles; Sarah K Barnes; Pawel F Tokarczuk; Sophie K Allen; Hilary S Whitworth; Irina A Guschina; Bronwen A J Evans; Agneta Mode; Jeffrey M Zigman; Timothy Wells
Journal:  Mol Endocrinol       Date:  2009-03-19

9.  Ghrelin receptor activity amplifies hippocampal N-methyl-d-aspartate receptor-mediated postsynaptic currents and increases phosphorylation of the GluN1 subunit at Ser896 and Ser897.

Authors:  Brandon G Muniz; Masako Isokawa
Journal:  Eur J Neurosci       Date:  2015-11-17       Impact factor: 3.386

10.  Disruption of cue-potentiated feeding in mice with blocked ghrelin signaling.

Authors:  Angela K Walker; Imikomobong E Ibia; Jeffrey M Zigman
Journal:  Physiol Behav       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.